All terms in GO
| Label | Id | Description |
|---|---|---|
| negative regulation of serotonin secretion | GO_0014063 | [Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of serotonin.] |
| negative regulation of secretion by cell | GO_1903531 | [Any process that stops, prevents or reduces the frequency, rate or extent of secretion by cell.] |
| negative regulation of neurotransmitter transport | GO_0051589 | [Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of a neurotransmitter into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.] |
| non-canonical Wnt signaling pathway via MAPK cascade | GO_0038030 | [The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, where the signal is passed on via the MAPKKK cascade.] |
| regulation of epinephrine secretion | GO_0014060 | [Any process that modulates the frequency, rate or extent of the regulated release of epinephrine.] |
| regulation of catecholamine secretion | GO_0050433 | [Any process that modulates the frequency, rate or extent of the regulated release of catecholamines.] |
| JNK cascade | GO_0007254 | [An intracellular protein kinase cascade containing at least a JNK (a MAPK), a JNKK (a MAPKK) and a JUN3K (a MAP3K). The cascade can also contain an additional tier: the upstream MAP4K. The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell.] |
| termination of G protein-coupled receptor signaling pathway | GO_0038032 | [The signaling process in which G protein-coupled receptor signaling is brought to an end. For example, through the action of GTPase-activating proteins (GAPs) that act to accelerate hydrolysis of GTP to GDP on G-alpha proteins, thereby terminating the transduced signal.] |
| termination of signal transduction | GO_0023021 | [The signaling process in which signal transduction is brought to an end rather than being reversibly modulated.] |
| reelin-mediated signaling pathway | GO_0038026 | [A series of molecular signals initiated by the binding of reelin (a secreted glycoprotein) to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.] |
| insulin receptor signaling pathway via phosphatidylinositol 3-kinase | GO_0038028 | [The series of molecular signals generated as a consequence of the insulin receptor binding to its physiological ligand, where the signal is passed on via the phosphatidylinositol 3-kinase cascade.] |
| epidermal growth factor receptor signaling pathway via MAPK cascade | GO_0038029 | [The series of molecular signals generated as a consequence of an epidermal growth factor receptor binding to one of its physiological ligands, where the signal is passed on via the MAPKKK cascade.] |
| G protein-coupled olfactory receptor activity | GO_0038022 | [Combining with an odorant and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex.] |
| molecular adaptor activity | GO_0060090 | [The binding activity of a molecule that brings together two or more molecules through a selective, non-covalent, often stoichiometric interaction, permitting those molecules to function in a coordinated way.] |
| reelin receptor activity | GO_0038025 | [Combining with the secreted glycoprotein reelin, and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.] |
| response to fluoxetine | GO_0014076 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fluoxetine stimulus. Fluoxetine increases the extracellular level of the neurotransmitter serotonin by inhibiting its reuptake into the presynaptic cell, increasing the level of serotonin available to bind to the postsynaptic receptor.] |
| response to antidepressant | GO_0036276 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antidepressant stimulus, a mood-stimulating drug.] |
| response to tropane | GO_0014073 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tropane stimulus. Tropane is a nitrogenous bicyclic organic compound mainly known for a group of alkaloids derived from it (called tropane alkaloids), which include, among others, atropine and cocaine.] |
| insulin receptor recycling | GO_0038020 | [The process that results in the return of an insulin receptor to an active state at the plasma membrane. An active state is when the receptor is ready to receive an insulin signal. Internalized insulin receptors can be recycled to the plasma membrane or sorted to lysosomes for protein degradation.] |
| receptor recycling | GO_0001881 | [The process that results in the return of receptor molecules to an active state and an active cellular location after they have been stimulated by a ligand. An active state is when the receptor is ready to receive a signal.] |